絞り込み

16532

広告

Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group.

著者 Pharithi RB , Ranganathan D , O'Brien J , Egom EE , Burke C , Ryan D , McAuliffe C , Vaughan M , Coughlan T , Morrissey E , McHugh J , Moore D , Collins R
Ir J Med Sci.2018 Jun 02 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (28view , 0users)

Miscellaneous

Non-vitamin K antagonist oral anticoagulants (NOACs) are a major advance for stroke prevention in atrial fibrillation (AF). Use of the vitamin K antagonist (VKA), warfarin, has dropped 40% since 2010 in our institution. There is limited Irish hospital data on NOAC prescribing for stroke prevention.
PMID: 29860595 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード